Lin CM and Hamel E |
Effects of inhibitors of tubulin polymerization on GTP hydrolysis. |
1981 |
J. Biol. Chem. |
pmid:6114958
|
Schrek R and Stefani SS |
Toxicity of microtubular drugs to leukemic lymphocytes. |
1981 |
Exp. Mol. Pathol. |
pmid:7238845
|
Stebbings H and van Bueren J |
Stability of microtubules from insect ovarioles. |
1981 |
Cell Biol. Int. Rep. |
pmid:7273149
|
Tanida S et al. |
Ansamitocin analogs from a mutant strain of Nocardia. I. Isolation of the mutant, fermentation and antimicrobial properties. |
1981 |
J. Antibiot. |
pmid:7275830
|
Izawa M et al. |
Ansamitocin analogs from a mutant strain of Nocardia. II. Isolation and structure. |
1981 |
J. Antibiot. |
pmid:7275831
|
Luduena RF and Roach MC |
Contrasting effects of maytansine and vinblastine on the alkylation of tubulin sulfhydryls. |
1981 |
Arch. Biochem. Biophys. |
pmid:7305339
|
Schatten G and Schatten H |
Effects of motility inhibitors during sea urchin fertilization: microfilament inhibitors prevent sperm incorporation and restructuring of fertilized egg cortex, whereas microtubule inhibitors prevent pronuclear migrations. |
1981 |
Exp. Cell Res. |
pmid:7308293
|
York J et al. |
Binding of maytansinoids to tubulin. |
1981 |
Biochem. Pharmacol. |
pmid:7317106
|
Wang XF et al. |
[Studies on the antitumor constituents of Maytenus confertiflora Luo et Chen (Celastraceae). II. Isolation and characterization of maytansine and maytanprine from the stems]. |
1981 |
Yao Xue Xue Bao |
pmid:7324964
|
Lin CM et al. |
Binding of maytansine to tubulin: competition with other mitotic inhibitors. |
1981 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:7255878
|
Nakahama K et al. |
Microbial conversion of ansamitocin. |
1981 |
J. Antibiot. |
pmid:7333971
|
Izawa M et al. |
Demethylation of ansamitocins and related compounds. |
1981 |
J. Antibiot. |
pmid:7333972
|
Izawa M et al. |
Hydroxylation of ansamitocin P-3. |
1981 |
J. Antibiot. |
pmid:7333973
|
Baskin F et al. |
Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. |
1981 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6943568
|
Edmonson JH et al. |
Phase II study of maytansine in advanced breast cancer. |
1981 May-Jun |
Cancer Treat Rep |
pmid:7237478
|
Ono Y et al. |
Antitumor and cytocidal activities of a newly isolated benzenoid ansamycin, macbecin I. |
1982 |
Gan |
pmid:6186564
|
Creech RH et al. |
Phase II study of cisplatin, maytansine, and chlorozotocin in small cell lung carcinoma (EST 2578). |
1982 |
Cancer Treat Rep |
pmid:6282460
|
Ratanatharathorn V et al. |
Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study. |
1982 |
Cancer Treat Rep |
pmid:7093975
|
Hatano K et al. |
Biosynthetic origin of aminobenzenoid nucleus (C7N-unit) of ansamitocin, a group of novel maytansinoid antibiotics. |
1982 |
J. Antibiot. |
pmid:7174527
|
Borden EC et al. |
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas. |
1982 |
Am. J. Clin. Oncol. |
pmid:6956236
|
Slavik M et al. |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience. |
1982 |
Am. J. Clin. Oncol. |
pmid:6897490
|
Perdue RE |
KB cell culture I. Role in discovery of antitumor agents from higher plants. |
1982 Jul-Aug |
J. Nat. Prod. |
pmid:7130986
|
deVere White R et al. |
Maytansine as a cause of acute proliferative disorder of bladder urothelium in the rat. |
1983 |
Cancer Treat Rep |
pmid:6825127
|
Thigpen JT et al. |
Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group study. |
1983 |
Am. J. Clin. Oncol. |
pmid:6846245
|
Edmonson JH et al. |
Phase II study of maytansine in advanced sarcomas. |
1983 |
Cancer Treat Rep |
pmid:6850657
|
Thigpen JT et al. |
Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. |
1983 |
Am. J. Clin. Oncol. |
pmid:6869315
|
Ghetti B and Gambetti P |
Comparative immunocytochemical characterization of neurofibrillary tangles in experimental maytansine and aluminum encephalopathies. |
1983 |
Brain Res. |
pmid:6354362
|
Fan YJ et al. |
[Use of 1,2:5,6-dianhydrogalactitol in combination with maytansine in experimental tumor therapy]. |
1983 |
Yao Xue Xue Bao |
pmid:6677049
|
Sabio H et al. |
Maytansine in refractory childhood acute lymphocytic leukemia: a Pediatric Oncology Group study. |
1983 |
Cancer Treat Rep |
pmid:6580069
|
Tsuruo T et al. |
Establishment and properties of vincristine-resistant human myelogenous leukemia K562. |
1983 |
Gan |
pmid:6580255
|
Akimoto H et al. |
Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones. |
1984 |
Chem. Pharm. Bull. |
pmid:6437689
|
Kawai A et al. |
Chemical modification of ansamitocins. III. Synthesis and biological effects of 3-acyl esters of maytansinol. |
1984 |
Chem. Pharm. Bull. |
pmid:6441645
|
Rebert CS et al. |
Effects of vincristine, maytansine, and cis-platinum on behavioral and electrophysiological indices of neurotoxicity in the rat. |
1984 |
J Appl Toxicol |
pmid:6542922
|
Roach MC and Ludueña RF |
Different effects of tubulin ligands on the intrachain cross-linking of beta 1-tubulin. |
1984 |
J. Biol. Chem. |
pmid:6480599
|
Niell HB et al. |
Effect of concentration and time of drug exposure on clonal growth of murine bladder cancer. |
1985 |
Urology |
pmid:2579500
|
|
Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group. |
1985 |
Cancer Treat Rep |
pmid:2859924
|
Fan YJ et al. |
[Effect of maytansine on the cell cycle of Ehrlich ascites carcinoma cells in mice]. |
1985 |
Zhongguo Yao Li Xue Bao |
pmid:3158164
|
Ravry MJ et al. |
Phase II evaluation of maytansine (NSC 153858) in advanced cancer. A Southeastern Cancer Study Group trial. |
1985 |
Am. J. Clin. Oncol. |
pmid:3834790
|
Gupta RS |
Species-specific differences in toxicity of antimitotic agents toward cultured mammalian cells. |
1985 |
J. Natl. Cancer Inst. |
pmid:3855475
|
Fellous A et al. |
Effects of Tau and MAP2 on the interaction of maytansine with tubulin: inhibitory effect of maytansine on vinblastine-induced aggregation of tubulin. |
1985 |
Cancer Res. |
pmid:3928146
|
Banerjee A et al. |
Interaction of reduced glutathione with bovine brain tubulin. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3994709
|
Huang AB et al. |
Maytansine inhibits nucleotide binding at the exchangeable site of tubulin. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:4004859
|
Sato Y et al. |
Induction of neurofibrillary tangles in cultured mouse neurons by maytanprine. |
1985 |
J. Neurol. Sci. |
pmid:4040155
|
Luduena RF et al. |
N,N'-Ethylene-bis(iodoacetamide) as a probe for structural and functional characteristics of brine shrimp, squid, and bovine tubulins. |
1985 |
Can. J. Biochem. Cell Biol. |
pmid:4041960
|
Schibler MJ and Cabral FR |
Maytansine-resistant mutants of Chinese hamster ovary cells with an alteration in alpha-tubulin. |
1985 |
Can. J. Biochem. Cell Biol. |
pmid:4041962
|
Duanmu C et al. |
Tubulin polymerization with ATP is mediated through the exchangeable GTP site. |
1986 |
Biochim. Biophys. Acta |
pmid:3004597
|
Tsuruo T et al. |
Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines. |
1986 |
Cancer Res. |
pmid:3753552
|
Luduena RF et al. |
Interactions of vinblastine and maytansine with tubulin. |
1986 |
Ann. N. Y. Acad. Sci. |
pmid:3460446
|
Yalowich JC |
Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro. |
1987 |
Cancer Res. |
pmid:2879622
|
Takahashi M et al. |
Rhizoxin binding to tubulin at the maytansine-binding site. |
1987 |
Biochim. Biophys. Acta |
pmid:3120782
|